Nicole L Davis1, Jeffrey Wiener1, Jonathan J Juliano2, Linda Adair3, Charles S Chasela4, Dumbani Kayira5, Michael G Hudgens6, Charles van der Horst2, Denise J Jamieson1, Athena P Kourtis1. 1. Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Infectious Diseases, Department of Medicine, School of Medicine. 3. Carolina Population Center, University of North Carolina at Chapel Hill, North Carolina, USA. 4. Division of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Parktown, South Africa. 5. University of North Carolina Project-Malawi, Lilongwe. 6. Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, North Carolina, USA
Abstract
Background: Human immunodeficiency virus (HIV)-exposed infants are disproportionately at risk of morbidity and mortality compared with their HIV-unexposed counterparts. The role of co-trimoxazole preventive therapy (CPT) in reducing leading causes of infectious morbidity is unclear. Methods: We used data from the Breastfeeding, Antiretrovirals and Nutrition (BAN) clinical trial (conducted 2004-2010, Malawi) to assess the association of (1) CPT and (2) asymptomatic malaria parasitemia with respiratory and diarrheal morbidity in infants. In June 2006, all HIV-exposed infants in BAN began receiving CPT (240 mg) from 6 to 36 weeks of age, or until weaning occurred and HIV infection was ruled out. All HIV-exposed, uninfected infants (HEIs) at 8 weeks of age (n = 1984) were included when CPT was the exposure. A subset of HEIs (n = 471) were tested for malarial parasitemia using dried blood spots from 12, 24, and 36 weeks of age. Cox proportional hazards models for recurrent gap-time data were used to examine the association of time-varying exposures on morbidity. Results: CPT was associated with a 36% reduction in respiratory morbidity (hazard ratio [HR], 0.64 [95% confidence interval {CI}, .60-.69]) and a 41% reduction in diarrheal morbidity (HR, 0.59 [95% CI, .54-.65]). Having asymptomatic malaria parasitemia was associated with a 40% increase in respiratory morbidity (HR, 1.40 [95% CI, 1.13-1.74]) and a 50% increase in diarrheal morbidity (HR, 1.50 [95% CI, 1.09-2.06]), after adjusting for CPT. Conclusions: CPT may have an important role to play in reducing the leading global causes of morbidity and mortality in the growing population of HEIs in malaria-endemic resource-limited settings. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Human immunodeficiency virus (HIV)-exposed infants are disproportionately at risk of morbidity and mortality compared with their HIV-unexposed counterparts. The role of co-trimoxazole preventive therapy (CPT) in reducing leading causes of infectious morbidity is unclear. Methods: We used data from the Breastfeeding, Antiretrovirals and Nutrition (BAN) clinical trial (conducted 2004-2010, Malawi) to assess the association of (1) CPT and (2) asymptomatic malaria parasitemia with respiratory and diarrheal morbidity in infants. In June 2006, all HIV-exposed infants in BAN began receiving CPT (240 mg) from 6 to 36 weeks of age, or until weaning occurred and HIV infection was ruled out. All HIV-exposed, uninfected infants (HEIs) at 8 weeks of age (n = 1984) were included when CPT was the exposure. A subset of HEIs (n = 471) were tested for malarial parasitemia using dried blood spots from 12, 24, and 36 weeks of age. Cox proportional hazards models for recurrent gap-time data were used to examine the association of time-varying exposures on morbidity. Results: CPT was associated with a 36% reduction in respiratory morbidity (hazard ratio [HR], 0.64 [95% confidence interval {CI}, .60-.69]) and a 41% reduction in diarrheal morbidity (HR, 0.59 [95% CI, .54-.65]). Having asymptomatic malaria parasitemia was associated with a 40% increase in respiratory morbidity (HR, 1.40 [95% CI, 1.13-1.74]) and a 50% increase in diarrheal morbidity (HR, 1.50 [95% CI, 1.09-2.06]), after adjusting for CPT. Conclusions: CPT may have an important role to play in reducing the leading global causes of morbidity and mortality in the growing population of HEIs in malaria-endemic resource-limited settings. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Steve M Taylor; Jonathan J Juliano; Paul A Trottman; Jennifer B Griffin; Sarah H Landis; Paluku Kitsa; Antoinette K Tshefu; Steven R Meshnick Journal: J Clin Microbiol Date: 2009-11-25 Impact factor: 5.948
Authors: Anna Dow; Dumbani Kayira; Michael Hudgens; Annelies Van Rie; Caroline C King; Sascha Ellington; Athena Kourtis; Abigail Norris Turner; Steven Meshnick; Zebrone Kacheche; Denise J Jamieson; Charles Chasela; Charles van der Horst Journal: Pediatr Infect Dis J Date: 2012-08 Impact factor: 2.129
Authors: Ai Koyanagi; Jean H Humphrey; Robert Ntozini; Kusum Nathoo; Lawrence H Moulton; Peter Iliff; Kuda Mutasa; Andrea Ruff; Brian Ward Journal: Pediatr Infect Dis J Date: 2011-01 Impact factor: 2.129
Authors: Alana T Brennan; Rachael Bonawitz; Christopher J Gill; Donald M Thea; Mary Kleinman; Johanna Useem; Lindsey Garrison; Rachel Ceccarelli; Chinenye Udokwu; Lawrence Long; Matthew P Fox Journal: AIDS Date: 2016-09-24 Impact factor: 4.177
Authors: Taylor G Sandison; Jaco Homsy; Emmanuel Arinaitwe; Humphrey Wanzira; Abel Kakuru; Victor Bigira; Julius Kalamya; Neil Vora; James Kublin; Moses R Kamya; Grant Dorsey; Jordan W Tappero Journal: BMJ Date: 2011-03-31
Authors: Li Liu; Shefali Oza; Daniel Hogan; Jamie Perin; Igor Rudan; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black Journal: Lancet Date: 2014-09-30 Impact factor: 79.321
Authors: Alexander C Ewing; Nicole L Davis; Dumbani Kayira; Mina C Hosseinipour; Charles van der Horst; Denise J Jamieson; Athena P Kourtis Journal: Emerg Infect Dis Date: 2019-01 Impact factor: 6.883
Authors: Emily L Deichsel; Patricia B Pavlinac; Dorothy Mbori-Ngacha; Judd L Walson; Elizabeth Maleche-Obimbo; Carey Farquhar; Rose Bosire; Grace C John-Stewart Journal: Am J Trop Med Hyg Date: 2020-05 Impact factor: 2.345